{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T04:36:45Z","timestamp":1784695005666,"version":"3.55.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Stroke is the most debilitating outcome of atrial fibrillation (AF). The use of implantable loop recorders increases the detection of AF episodes among patients with embolic stroke of undetermined source. The significance of device-detected AF, or subclinical AF, is unknown. This study aimed to compare the incidence of AF detected by implantable loop recorder in patients with and without embolic stroke of undetermined source.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>We retrospectively studied all patients without known AF who were referred to our institution for implantable loop recorder implantation following embolic stroke of undetermined source, syncope, or palpitations from March 2009 to November 2019. The primary endpoint was any detection of AF or atrial flutter by implantable loop recorder. Seven hundred and fifty patients were included and followed up for a mean duration of 731 days (SD 443). An implantable loop recorder was implanted following embolic stroke of undetermined source in 323 and for assessment of syncope, palpitations, or another reason in 427 patients. The incidence of AF was significantly (P &amp;lt; 0.001) higher among patients with embolic stroke of undetermined source compared with the non-embolic stroke of undetermined source group; 48.6% vs. 13.8% (for any duration of AF) and 32.2% vs. 12.4% (for AF lasting \u226530\u2005s) both P &amp;lt; 0.001. Kaplan\u2013Meier analysis showed significantly higher incidence of AF for incremental durations of AF up to &amp;gt;5.5\u2005h, but not &amp;gt;24\u2005h. This was driven by longest AF durations of &amp;lt;6\u2005min and between 5.5\u2005h and 24\u2005h, suggesting a bimodal distribution. In a multivariable Cox regression analysis, embolic stroke of undetermined source independently conferred an almost 5-fold increase in the hazard for any duration of AF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The incidence of AF is significantly higher amongst embolic stroke of undetermined source vs. non-embolic stroke of undetermined source patients monitored constantly by an implantable loop recorder. A high number of embolic stroke of undetermined source survivors have short-duration AF episodes. Further work is needed to determine the optimal treatment strategy of these AF episodes in embolic stroke of undetermined source.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjopen\/oeae061","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T13:51:33Z","timestamp":1725198693000},"source":"Crossref","is-referenced-by-count":7,"title":["The incidence of atrial fibrillation detected by implantable loop recorders: a comparison between patients with and without embolic stroke of undetermined source"],"prefix":"10.1093","volume":"4","author":[{"given":"Panagiota A","family":"Chousou","sequence":"first","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich, Norfolk NR4 7TJ ,","place":["UK"]},{"name":"Department of Cardiology, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust , Hill's Road, Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul K","family":"Chattopadhyay","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich, Norfolk NR4 7TJ ,","place":["UK"]},{"name":"Department of Cardiology, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust , Hill's Road, Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8353-4806","authenticated-orcid":false,"given":"Gareth","family":"Matthews","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich, Norfolk NR4 7TJ ,","place":["UK"]},{"name":"Department of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Clark","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich, Norfolk NR4 7TJ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4005-7752","authenticated-orcid":false,"given":"Vassilios S","family":"Vassiliou","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich, Norfolk NR4 7TJ ,","place":["UK"]},{"name":"Department of Cardiology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Pugh","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich, Norfolk NR4 7TJ ,","place":["UK"]},{"name":"Department of Cardiology, Addenbrooke\u2019s Hospital, Cambridge University Hospitals NHS Foundation Trust , Hill's Road, Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,1]]},"reference":[{"key":"2024103011584861300_oeae061-B1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"2024103011584861300_oeae061-B2","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jelectrocard.2018.08.033","article-title":"Prevalence of atrial fibrillation with insertable cardiac monitors in cryptogenic stroke: a single-center experience","volume":"51","author":"Asaithambi","year":"2018","journal-title":"J Electrocardiol"},{"key":"2024103011584861300_oeae061-B3","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"2024103011584861300_oeae061-B4","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"2024103011584861300_oeae061-B5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"2024103011584861300_oeae061-B6","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the MOde Selection Trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"key":"2024103011584861300_oeae061-B7","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/europace\/eux163","article-title":"Device-detected subclinical atrial tachyarrhythmias: definition, implications and management","volume":"19","author":"Gorenek","year":"2017","journal-title":"Europace"},{"key":"2024103011584861300_oeae061-B8","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"key":"2024103011584861300_oeae061-B9","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.0b013e31828f1828","article-title":"Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke","volume":"80","author":"Cotter","year":"2013","journal-title":"Neurology"},{"key":"2024103011584861300_oeae061-B10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijcard.2017.06.039","article-title":"Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population","volume":"244","author":"Ziegler","year":"2017","journal-title":"Int J Cardiol"},{"key":"2024103011584861300_oeae061-B11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/STROKEAHA.111.676189","article-title":"Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors","volume":"44","author":"Ritter","year":"2013","journal-title":"Stroke"},{"key":"2024103011584861300_oeae061-B12","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/STROKEAHA.113.003788","article-title":"Supraventricular premature beats and short atrial runs predict atrial fibrillation in continuously monitored patients with cryptogenic stroke","volume":"45","author":"Kochh\u00e4user","year":"2014","journal-title":"Stroke"},{"key":"2024103011584861300_oeae061-B13","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1093\/eurjpc\/zwad228","article-title":"Atrial fibrillation in embolic stroke of undetermined source: role of advanced imaging of left atrial function","volume":"30","author":"Chousou","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"2024103011584861300_oeae061-B14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.amjcard.2003.11.042","article-title":"Prognostic differences between atrial fibrillation and atrial flutter","volume":"93","author":"Lelorier","year":"2004","journal-title":"Am J Cardiol"},{"key":"2024103011584861300_oeae061-B15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2007.08.066","article-title":"Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications","volume":"51","author":"Waldo","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2024103011584861300_oeae061-B16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/europace\/euw279","article-title":"Atrial high-rate episodes and stroke prevention","volume":"19","author":"Camm","year":"2017","journal-title":"Europace"},{"key":"2024103011584861300_oeae061-B17","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"20","author":"Calkins","year":"2018","journal-title":"Europace"},{"key":"2024103011584861300_oeae061-B18","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","article-title":"Implantable loop recorder detection of atrial fibrillation to prevent stroke (the LOOP study): a randomised controlled trial","volume":"398","author":"Svendsen","year":"2021","journal-title":"Lancet"},{"key":"2024103011584861300_oeae061-B19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"2024103011584861300_oeae061-B20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"2024103011584861300_oeae061-B21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2024103011584861300_oeae061-B22","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"2024103011584861300_oeae061-B23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41569-023-00857-3","article-title":"The bidirectional association between atrial fibrillation and myocardial infarction","volume":"20","author":"Frederiksen","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"2024103011584861300_oeae061-B24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/eurheartj\/ehaa822","article-title":"Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective","volume":"42","author":"Simons","year":"2021","journal-title":"Eur Heart J"},{"key":"2024103011584861300_oeae061-B25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/ene.13538","article-title":"Refinement of detecting atrial fibrillation in stroke patients: results from the TRACK-AF study","volume":"25","author":"Reinke","year":"2018","journal-title":"Eur J Neurol"},{"key":"2024103011584861300_oeae061-B26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.117.028845","article-title":"Subclinical atrial fibrillation in older patients","volume":"136","author":"Healey","year":"2017","journal-title":"Circulation"},{"key":"2024103011584861300_oeae061-B27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.hrthm.2017.04.026","article-title":"Predicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) study","volume":"14","author":"Nasir","year":"2017","journal-title":"Heart Rhythm"},{"key":"2024103011584861300_oeae061-B28","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamacardio.2017.3180","article-title":"Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population","volume":"2","author":"Reiffel","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2024103011584861300_oeae061-B29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ahj.2019.09.009","article-title":"Incidence and predictors of atrial fibrillation episodes as detected by implantable loop recorder in patients at risk: from the LOOP study","volume":"219","author":"Diederichsen","year":"2020","journal-title":"Am Heart J"},{"key":"2024103011584861300_oeae061-B30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/pace.12692","article-title":"Demographic and clinical characteristics to predict paroxysmal atrial fibrillation: insights from an implantable loop recorder population","volume":"38","author":"Frontera","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"2024103011584861300_oeae061-B31","first-page":"S1050-1738(24)00032-X","article-title":"Thromboembolic risk and oral anticoagulation in subclinical atrial fibrillation","author":"Wegner","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"2024103011584861300_oeae061-B32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/ene.14061","article-title":"Ultra-early continuous cardiac monitoring improves atrial fibrillation detection and prognosis of patients with cryptogenic stroke","volume":"27","author":"Cuadrado-Godia","year":"2020","journal-title":"Eur J Neurol"},{"key":"2024103011584861300_oeae061-B33","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5551\/jat.61895","article-title":"Recurrent stroke incidence and etiology in patients with embolic stroke of undetermined source and other stroke subtypes","volume":"29","author":"Toi","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"2024103011584861300_oeae061-B34","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jamaneurol.2022.3031","article-title":"Severity and etiology of incident stroke in patients screened for atrial fibrillation vs usual care and the impact of prior stroke: a post hoc analysis of the LOOP randomized clinical trial","volume":"79","author":"Diederichsen","year":"2022","journal-title":"JAMA Neurol"},{"key":"2024103011584861300_oeae061-B35","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESIA trials","volume":"149","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"2024103011584861300_oeae061-B36","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"key":"2024103011584861300_oeae061-B37","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"},{"key":"2024103011584861300_oeae061-B38","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jamaneurol.2019.0617","article-title":"Recurrent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibrillation: secondary analysis of the NAVIGATE ESUS randomized clinical trial.","volume":"76","author":"Healey","year":"2019","journal-title":"JAMA Neurol"},{"key":"2024103011584861300_oeae061-B39","doi-asserted-by":"crossref","first-page":"EVIDoa2300235","DOI":"10.1056\/EVIDoa2300235","article-title":"Apixaban versus aspirin for embolic stroke of undetermined source","volume":"3","author":"Geisler","year":"2023","journal-title":"NEJM Evid"},{"key":"2024103011584861300_oeae061-B40","first-page":"30","article-title":"Electrocardiographic predictors of atrial fibrillation","volume":"11","author":"Chousou","year":"2023","journal-title":"Med Sci (Basel)"},{"key":"2024103011584861300_oeae061-B41","doi-asserted-by":"crossref","first-page":"e0278527","DOI":"10.1371\/journal.pone.0278527","article-title":"The predictive value of abnormal P-wave axis for the detection of incident atrial fibrillation: a systematic review with meta-analysis","volume":"17","author":"Chattopadhyay","year":"2022","journal-title":"PLoS One"},{"key":"2024103011584861300_oeae061-B42","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of &gt;10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"2024103011584861300_oeae061-B43","doi-asserted-by":"crossref","first-page":"268","DOI":"10.12659\/MSM.890052","article-title":"Incidence of new onset atrial fibrillation in patients with permanent pacemakers and the relation to the pacing mode","volume":"20","author":"Said","year":"2014","journal-title":"Med Sci Monit"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/4\/5\/oeae061\/60197449\/oeae061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/4\/5\/oeae061\/60197449\/oeae061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T16:17:38Z","timestamp":1730305058000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oeae061\/7745793"}},"subtitle":[],"editor":[{"given":"Denis","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,8,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oeae061","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,8,31]]},"article-number":"oeae061"}}